The search for eternal youth marches on with a new grant from the National Institute on Aging for work to continue on the effects of the drug rapamycin on the lifespan and healthy aging of middle aged marmoset monkeys. The grant comes on the heels of a study with the animals showing the anti-aging drug has minimal metabolic side effects after continuous, long-term treatment.
